Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks
Rasul, Sazan, Hacker, Marcus, Kretschmer-Chott, Elisabeth, Leisser, Asha, Grubmüller, Bernhard, Kramer, Gero, Shariat, Shahrokh, Wadsak, Wolfgang, Mitterhauser, Markus, Hartenbach, Markus, Haug, AlexaLanguage:
english
Journal:
European Journal of Nuclear Medicine and Molecular Imaging
DOI:
10.1007/s00259-019-04584-1
Date:
November, 2019
File:
PDF, 926 KB
english, 2019